基本信息
浏览量:225
职业迁徙
个人简介
Dr. Garnet Anderson is a biostatistician and clinical trialist who focuses on chronic disease prevention and women's health. She is best known for her leadership role in the Women’s Health Initiative, a national effort to test methods to reduce the risk of cancer, cardiovascular disease and fractures related to osteoporosis in postmenopausal women. In 2002, she and her WHI colleagues reported that menopausal estrogen-plus-progestin therapy increased the risk of breast cancer, coronary heart disease, stroke and blood clots. These findings led to a rapid reduction in use of these hormones. Subsequent analyses led by Hutch colleagues estimated these changes prevented 126,000 breast cancer diagnoses and saved approximately $35.2 billion in direct medical expenses in the U.S. alone over 10 years after the trial.
研究兴趣
论文共 403 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Hailey R. Banack,Jean Wactawski-Wende,Heather M. Ochs-Balcom, Elizabeth M. Cespedes Feliciano,Bette Caan,Catherine Lee,Garnet Anderson,Mahalakshmi Shankaran,William J. Evans
PLoS ONEno. 4 (2024)
The Lancet Gastroenterology & Hepatologyno. 1 (2024): 15-15
Cancer Researchno. 6_Supplement (2024): 4772-4772
Robert S. Krouse,Garnet L. Anderson,Kathryn B. Arnold,Virginia Sun,Angeles Alvarez Secord,Gary B. Deutsch, Jeremiah L. Deneve
LANCET GASTROENTEROLOGY & HEPATOLOGYno. 1 (2024): 15-15
引用0浏览0引用
0
0
crossref(2023)
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Researchno. 6 (2023): S213-S214
引用0浏览0WOS引用
0
0
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn